期刊文献+

细胞学联合人乳头瘤病毒杂交捕获检测在宫颈上皮内瘤样病变筛查中应用 被引量:17

Clinical significance of combined detection of thinprep cytology test and high risk human papillomavirus hybrid capture 2 assay in the screening and recurrence predication of cervical intraepithelial neoplasia
原文传递
导出
摘要 目的探讨液基薄层液基细胞学(TCT)、人乳头瘤病毒高危型杂交捕获(HR.HPV.HC2)联合检测筛查宫颈上皮内瘤样病变(CIN)及预警其术后复发临床价值。方法对2009至2011年嘉兴市妇幼保健院的725例疑似CIN患者同时进行TCT、HR.HPV—HC2检测和多点锥切活组织检查确诊。对203例CINⅡ~Ⅲ级患者行宫颈leep术或冷刀锥切术,术后进行TCT、HR.HPV.HC2和多点锥切活检随访。分析TCT、HR—HPV—HC2单独和联合检测筛查CIN和预警其术后复发的灵敏度。结果TCT、HC2单独检测初筛诊断CIN的漏诊率、误诊率分别为19.23%(40/208)、12.50%(12/96)和48.15%(156/324)、74.07%(240/324),敏感性、特异性分别为90.02%、97.01%和51.85%、17.76%。TCT、HC2联合检测满足其一即初筛诊断CIN的敏感性98.25%,漏诊率1.75%,阴性预测值89.70%;二者均需满足才能初筛诊断CIN的特异性58.95%,阳性预测值72.80%。TCT、HC2单独检测预警CIN术后6个月复发特异性80%左右;二者联合检测且均需满足才能诊断CIN术后复发,3个月特异性98.27%,6个月阴性预测值98.75%;二者联合检测且只需满足其一即诊断CIN术后复发的3、6个月敏感性均97.22%,6个月阴性预测值99.17%。结论TCT、HC2联合检测,可明显提高CIN预警及术后复发的敏感性和特异性。 Objective To evaluate the clinical significance of combined detection of TCT and HR- HPV-HC2 assay in the screening and recurrence prediction of CIN. Methods A total of 725 patients with suspected cervical abnormalities received TCT plus HR-HPV-HC2 detection and histopathological examinations. 203 CINⅡ~Ⅲ patients received TCT and HC2 detection and histopathological examinations after treated with loop electrosurgical excision procedure or cold knife conization operation. The results of pathological examinations were gold standard. The sensitivity and specificity of TCT, HR-HPV-HC2 and TCT plus HR-HPV-HC2 were analyzed. Results The missed diagnosis and misdiagnosis rate of TCT and HC2 alone were 19. 23%, 12. 50% and 48. 15%, 74. 07% and sensitivity and specificity 90.02%, 97. 01% and 51.85%, 17.76% respectively. The sensitivity, missed diagnosis rate and negative predictive value were 98. 25% , 1.75% and 89.70% when TCT or specificity and positive predictive value were 58.95% HR-HPV-HC2 met the CIN diagnostic criteria. The and 72. 80% when TCT and HR-HPV-HC2 met the CIN diagnostic criteria. The specificity of TCT or HR-I-IPV-HC2 alone was 80% for the prediction of recurrence at Month 6 postoperation. The specificity of TCT plus HR-HPV-HC2 was 98.27% for the prediction of recurrence at Month 3 postoperation and the negative predictive value was 98.75% at Month 6 postoperation. The sensitivity of TCT or HR-HPV-HC2 was 97.22% for the prediction of recurrence at Month 3/6. And the negative predictive value was 99. 17% at Month 6 postoperation. Conclusion The combined detection of TCT and HR-HPV-HC2 may improve the sensitivity and specificity of CIN and the predication of its postoperative recurrence.
出处 《中华医学杂志》 CAS CSCD 北大核心 2012年第35期2503-2505,共3页 National Medical Journal of China
基金 基金项目:嘉兴市2008年度科技计划(2008AY2035)
关键词 细胞学技术 人乳头瘤病毒 宫颈上皮内瘤样病变 Cytological techniques Human papillomavirus Cervical intraepithelial neoplasia
  • 相关文献

参考文献6

二级参考文献45

  • 1李荣.TCT检测在宫颈癌筛查中的临床应用[J].江苏医药,2007,33(5):516-517. 被引量:26
  • 2Weaver BA. Epidemiology and natural history of genital human papillomavirus infection [J] . Am Osteopath Assoc, 2006, 106 (3Suppl 1 ) : S2. 被引量:1
  • 3Khan MD, Castle PE, Lorincz AT et al. The elevated 10 - year risk of cervical pre - cancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type - specific HPV testing in clinical practice [J] . Cancer lust, 2005, 97 (14) : 1072. 被引量:1
  • 4Verguts J, Bronselaer B, Donders G et al. Prediction of recurrence after treatment for high - grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation [ J]. BJOG, 2006, 113 (11): 1303. 被引量:1
  • 5Cronje HS.Screening for cervical cancer in developing countries[J].Int J Gynaecol Obstet,2004,84(2):101-108. 被引量:1
  • 6Pimple S,Muwonge R,Amin G,et al.Cytology versus HPV testing for the detection of high-grade cervical lesions in women found positive on visual inspection in Mumbai,India[J].Int J Gynaecol Obstet,2010,108:236-239. 被引量:1
  • 7Lee KRR,Ashfag GG,Birdsong ME,et al.Comparision of conventionl papanicolaou smears and a fluid-based,thin-layer system for cervical cancer screening[J].Obstet Gynecol,1997,90:278-284 被引量:1
  • 8Schiffman MR,Herrero A,Hildesheim ME,et al.HPV DNA testing in cervical cancer screening:results from women in a high-risk province of Costa Rica[J].JAMA,2000,283:87-93 被引量:1
  • 9Elieen M.Human papillomavirus and cervical cancer[J].Clin Microbiol Res,2003,16:1-17 被引量:1
  • 10Walboomers JMM.Jacobs MM,Manos FX,et al.Human papillmomavirus is a necessary cause of invasive cervical cancer worldwide[J].J Pathol,1999,189:12-19 被引量:1

共引文献70

同被引文献114

引证文献17

二级引证文献141

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部